Key market opportunities include advances in AI algorithms for improved stroke diagnosis and faster triage, increasing ...

Among patients with LVO-related AIS undergoing EVT, general anesthesia is linked to better 90-day recovery and functional independence vs sedation.

Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic stroke (AIS), today announced that the first ...

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

Predictors of short-term outcomes after endovascular therapy for acute ischemic stroke include age, neurologic status, and postsurgical complications, new research shows.

Stroke patients in Pickerington can now receive critical care closer to home thanks to OhioHealth’s new thrombectomy ...

Over nearly the last three decades, Genentech has had the lone medicine on the market for the acute treatment of stroke. Monday, the Roche subsidiary added a second stroke treatment to its repertoire, ...

Stroke remains one of the leading causes of death and disability worldwide. Although strong evidence demonstrates that up to 80% of strokes are preventable, ...

BASEL, Switzerland—Multiple randomized trials presented last week at the European Stroke Organisation Conference (ESOC) 2024 have bolstered the case that tenecteplase (TNK) is an effective—if not ...

There are “significant” staffing shortages in stroke units in hospitals, with three-quarters of recommended staff numbers ...